Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial

Autor Cairo, Mitchell S., Talano, Julie-An, Moore, Theodore B., Shi, Qiuhu, Weinberg, Rona Singer, Grossman, Brenda, Shenoy, Shalini
Vydáno v JAMA Pediatr (2020)

Ruxolitinib Therapy Followed by Reduced Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis – Myeloproliferative Disorders Research Consortium 114 study...

Autor Gupta, Vikas, Kosiorek, Heidi E., Mead, Adam, Klisovic, Rebecca B, Galvin, John P., Berenzon, Dmitriy, Yacoub, Abdulraheem, Viswabandya, Auro, Mesa, Ruben A., Goldberg, Judith, Price, Leah, Salama, Mohamed E, Weinberg, Rona Singer, Rampal, Raajit, Farnoud, Noushin, Dueck, Amylou C., Mascarenhas, John O., Hoffman, Ronald
Vydáno v Biol Blood Marrow Transplant (2018)

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms

Autor Rampal, Raajit K., Mascarenhas, John O., Kosiorek, Heidi E., Price, Leah, Berenzon, Dmitriy, Hexner, Elizabeth, Abboud, Camille N., Kremyanskaya, Marina, Weinberg, Rona Singer, Salama, Mohamed E., Menghrajani, Kamal, Najfeld, Vesna, Sandy, Lonette, Heaney, Mark L., Levine, Ross L., Mesa, Ruben A., Dueck, Amylou C., Goldberg, Judith D., Hoffman, Ronald
Vydáno v Blood Adv (2018)

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Autor Mascarenhas, John O., Rampal, Raajit K., Kosiorek, Heidi E., Bhave, Rupali, Hexner, Elizabeth, Wang, Eunice S., Gerds, Aaron, Abboud, Camille N., Kremyanskaya, Marina, Berenzon, Dimitry, Odenike, Olatoyosi, Farnoud, Noushin, Krishnan, Aishwarya, Weinberg, Rona Singer, McGovern, Erin, Salama, Mohamed E., Najfeld, Vesna, Medina-Martinez, Juan S., Arango Ossa, Juan E., Levine, Max F., Zhou, Yangyu, Sandy, Lonette, Heaney, Mark L., Levine, Ross L., Mesa, Ruben A., Dueck, Amylou C., Hoffman, Ronald
Vydáno v Blood Adv (2020)

CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms

Autor Meyer, Sara C., Keller, Matthew D., Chiu, Sophia, Koppikar, Priya, Guryanova, Olga A., Rapaport, Franck, Xu, Ke, Manova, Katia, Pankov, Dmitry, O’Reilly, Richard J., Kleppe, Maria, McKenney, Anna Sophia, Shih, Alan H., Shank, Kaitlyn, Ahn, Jihae, Papalexi, Eftymia, Spitzer, Barbara, Socci, Nick, Viale, Agnes, Mandon, Emeline, Ebel, Nicolas, Andraos, Rita, Rubert, Joëlle, Dammassa, Ernesta, Romanet, Vincent, Dölemeyer, Arno, Zender, Michael, Heinlein, Melanie, Rampal, Rajit, Weinberg, Rona Singer, Hoffman, Ron, Sellers, William R., Hofmann, Francesco, Murakami, Masato, Baffert, Fabienne, Gaul, Christoph, Radimerski, Thomas, Levine, Ross L.
Vydáno v Cancer Cell (2015)